Additional, Specialized Radiation Not Necessary For Some Women After Mastectomy

 03.11.2009 04:15   medicalnewstoday.com

After mastectomy, breast cancer patients who receive radiation treatment to the lymph nodes located behind the breast bone do not live longer than those who do not receive radiation to this hard-to-treat area, according to a randomized 10-year study presented at the plenary session, November 2, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

World Cancer

American Society Of Clinical Oncology (ASCO) Statement On Cuts To Cancer Care In 2010 Medicare Physician Fee Schedule

Below is a statement for attribution to ASCO CEO Allen S. Lichter, MD: "Today, CMS issued its ph...

Celldex Therapeutics Presents Positive Clinical Data From Phase 1 Studies Of Antibody-Based Cancer Vaccine Candidate, CDX-1307

Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced positive results from Phase 1 studies of CDX-...

Studies Show Early Promise Of MannKind's Cancer Immunotherapy Program In Melanoma, Prostate Cancer And Other Solid Malignancies

Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106&#...

Imaging Systems From GE Healthcare Spotlight The Possibilities Of Connected Oncology Care At ASTRO 2009

According to the American Cancer Society, more than one million people are diagnosed with cancer eac...

Covidien Receives FDA Approval For Oral Transmucosal Fentanyl Citrate Product

Covidien (NYSE: COV), a leading global provider of healthcare products, announced that its subsidiar...

Gastrocor(R) Introduces New FISH Test For Colorectal Cancer Detection

GastroFISH™ is the first tissue-based fluorescence in situ hybridization (FISH) test for ...

Completion Of Phase I Clinical Trial Of Sancuso(R) In Japanese Volunteers

Solasia Pharma K.K., a developer of Western oncology pharmaceuticals in-licensed for commerciali...

BSD Medical Reports Hyperthermia Therapy Contributes To Improved Survival Rate For Bladder Cancer Patients

BSD Medical Corporation (NASDAQ:BSDM) announced that published study results demonstrated improvemen...

Brain Tumors In Childhood Leave A Lasting Mark On Cognition, Life Status

Brain tumors in childhood cast a long shadow on survivors. The first study of the lasting impact of ...

Mentor Capital, Inc. Rated A $5/sh Speculative Buy On Immune System Breast Cancer Treatment In FDA Phase I/II Trials

Mentor Capital, Inc. (Pink Sheets: MNTR) is well poised to be a significant participant in the expan...